Format

Send to

Choose Destination
See comment in PubMed Commons below
J Perinat Med. 2012 May 13;40(5):475-81. doi: 10.1515/jpm-2011-0277.

Trophoblastic progranulin expression is upregulated in cases of fetal growth restriction and preeclampsia.

Author information

1
Department of Obstetrics and Gynecology, University of Rostock, Suedring 81, Rostock 18059, Germany. johannes.stubert@uni-rostock.de

Abstract

AIMS:

The expression of the anti-inflammatory glycoprotein progranulin and the hypoxia-induced transcription factor 1α (HIF-1α) in the villous trophoblast was compared between placentae from patients with preeclampsia (PE), fetal growth restriction (FGR), and normal controls.

STUDY DESIGN:

Matched pairs analysis of third trimester placentae specimens (mean gestational age 36+2) was performed by semiquantitative measurements of the immunohistochemical staining intensities for progranulin and HIF-1α expression (PE n=13, FGR n=9 and controls n=11). Further, placental progranulin mRNA expression was analyzed by qRT-PCR on term placentae (n=3 for each group).

RESULTS:

Compared to controls, villous trophoblast revealed a significantly higher expression of progranulin in cases of PE (P<0.05) and FGR (P<0.01). Similar results were shown for HIF-1α expression (P<0.01 for PE and <0.05 for FGR). The increase of the progranulin protein was not accompanied by an increase of the progranulin mRNA in term placentae.

CONCLUSIONS:

Increased expression of progranulin protein in villous trophoblast cells in cases of PE and FGR may result from disturbed placental development and, therefore, may be of pathogenetic importance. The increase was correlated to HIF-1α expression. Further evaluation of this potential mechanism of regulation is required.

PMID:
22945272
DOI:
10.1515/jpm-2011-0277
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for iFactory
    Loading ...
    Support Center